Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug

Ibrahim N. Mwangi1, Melissa C. Sanchez2, Gerald M. Mkoji1, Lelo E. Agola1, Steven M. Runo3, Pauline M. Cupit2, Charles Cunningham2
1Center for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi, Kenya
2Dept. of Biology, University of New Mexico, Albuquerque, NM 87131, USA
3Dept. of Biochemistry and Biotechnology, Kenyatta University, Nairobi, Kenya

Tài liệu tham khảo

Alonso, 2006, Failure of standard treatment with praziquantel in two returned travellers with Schistosoma haematobium infection, Am. J. Trop. Med. Hyg., 74, 342, 10.4269/ajtmh.2006.74.342 Aragon, 2009, Towards an understanding of the mechanism of action of praziquantel, Mol. Biochem. Parasitol., 164, 57, 10.1016/j.molbiopara.2008.11.007 Coeli, 2013, Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections, PLoS Negl. Trop. Dis., 7, e2596, 10.1371/journal.pntd.0002596 Couto, 2011, Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails, Mem. Inst. Oswaldo Cruz, 106, 153, 10.1590/S0074-02762011000200006 Delgado, 1992, Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite, Parasitol. Res., 78, 648, 10.1007/BF00931515 Fallon, 1994, Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific, Am. J. Trop. Med. Hyg., 53, 83, 10.4269/ajtmh.1994.51.83 Fallon, 1997, Schistosoma mansoni: maturation rate and drug susceptibility of different geographical isolates, Exp. Parasitol., 86, 29, 10.1006/expr.1997.4149 French, 2013, Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition, Acta Trop., 128, 196, 10.1016/j.actatropica.2012.03.001 Guidi, 2010, Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island, Trop. Med. Int. Health, 15, 614 Hagan, 2004, Schistosomiasis control: keep taking the tablets, Trends Parasitol., 20, 92, 10.1016/j.pt.2003.11.010 Huyse, 2013, Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal, Infect. Genet. Evol., 18, 100, 10.1016/j.meegid.2013.05.007 Ismail, 1999, Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers, Am. J. Trop. Med. Hyg., 60, 932, 10.4269/ajtmh.1999.60.932 King, 2010, Parasites and poverty: the case of schistosomiasis, Acta Trop., 113, 95, 10.1016/j.actatropica.2009.11.012 Lamberton, 2010, In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections, Am. J. Trop. Med. Hyg., 83, 1340, 10.4269/ajtmh.2010.10-0413 Liang, 2001, In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel, Int. J. Parasitol., 11, 1227, 10.1016/S0020-7519(01)00246-6 Melman, 2009, Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni, PLoS Negl. Trop. Dis., 18, e504, 10.1371/journal.pntd.0000504 Mendonca da Silva, 2005, Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa, Mem. Inst. Oswaldo Cruz, 100, 445, 10.1590/S0074-02762005000400018 Norton, 2010, Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania, Am. J. Trop. Med. Hyg., 83, 951, 10.4269/ajtmh.2010.10-0283 Pica-Mattoccia, 2004, Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment, Int. J. Parasitol., 34, 527, 10.1016/j.ijpara.2003.12.003 Pica-Mattoccia, 2009, Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni, Acta Trop., 111, 82, 10.1016/j.actatropica.2009.01.012 Stelma, 1995, Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni, Am. J. Trop. Med. Hyg., 53, 167, 10.4269/ajtmh.1995.53.167 William, 2001, Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel, Int. J. Parasitol., 31, 1093, 10.1016/S0020-7519(01)00215-6 World Health Organization, 2012. Accelerating work to overcome the global impact of neglected tropical diseases – a roadmap for implementation executive summary. WHO/HTM/NTD/2012.1. World Heath Organization, Switzerland, Geneva. World Health Organization, 2014, Schistosomiasis: number of people receiving preventative chemotherapy in 2012, Wkly. Epidemiol. Rec., 89, 21